Home›Search›Blood and Lymphatic Cancer: Targets and Therapy

Blood and Lymphatic Cancer: Targets and Therapy

Dove Medical Press · United Kingdom

eISSN1179-9889
✓ WOS ESCI✓ DOAJ✓ Open Access
68
/ 100
Established
PubScope credibility score from verifiable indexing & ethics signals
Score Breakdown
◆ WoS ESCI56
✓ Corroboration (2 more)+12
Total68
Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (ESCI) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Source: Clarivate Journal Citation Reports.

Aims & Scope

The journal welcomes submitted papers covering original research, basic science, clinical & epidemiological studies, reviews & evaluations, guidelines, expert opinion and commentary, case reports, and extended reports.

General Information

Country / RegionUnited Kingdom
Primary LanguageEnglish
1st Year Published—
StatusActive
Total Publications—
Publisher OrgDove Medical Press
Visit Journal Website

Submission Info

APC Cost$3,300Above median
Peer ReviewAnonymous peer review
Review Time—
Acceptance Rate—
OA LicenseCC BY, CC BY-NC
OA Rate—

Ethics & Quality

COPE Member✗ No
OASPA Member✗ No
Not on Predatory Lists✓ Yes
Plagiarism Detection✓ Yes

Think.Check.Submit Compliance

10/12 · 83%
✅
Do you know the journal / publisher?
Dove Medical Press
✅
Does the journal have a website?
✓ Linked
✅
Is the ISSN verified?
1179-9889
✅
Indexed in a trusted database?
WoS, DOAJ, PubMed
✅
Peer review process documented?
Anonymous peer review
❌
Follows ethical publishing standards (COPE)?
N/A
✅
APC fees clearly disclosed?
$3,300
✅
Not on predatory/blacklists?
✓ Clean
❌
Long-term digital preservation?
N/A
✅
Plagiarism detection in place?
Yes
✅
Listed in DOAJ (verified OA)?
DOAJ verified
✅
Primary language documented?
English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Subject Classification

Web of Science Categories

Oncology

Research Topics (OpenAlex)

Lymphoma Diagnosis and TreatmentChronic Lymphocytic Leukemia ResearchAcute Myeloid Leukemia ResearchAcute Lymphoblastic Leukemia researchMultiple Myeloma Research and TreatmentsChronic Myeloid Leukemia TreatmentsCAR-T cell therapy researchCNS Lymphoma Diagnosis and TreatmentProtein Degradation and InhibitorsMyeloproliferative Neoplasms: Diagnosis and Treatment

Frequently asked questions about Blood and Lymphatic Cancer: Targets and Therapy

Is Blood and Lymphatic Cancer: Targets and Therapy a predatory journal?

PubScope has no integrity flags on record for Blood and Lymphatic Cancer: Targets and Therapy: it is indexed in Web of Science, DOAJ, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 68/100. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Blood and Lymphatic Cancer: Targets and Therapy?

Blood and Lymphatic Cancer: Targets and Therapy is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date.

Is Blood and Lymphatic Cancer: Targets and Therapy indexed in Scopus and Web of Science?

Blood and Lymphatic Cancer: Targets and Therapy is indexed in Web of Science, DOAJ.

What is the aims and scope of Blood and Lymphatic Cancer: Targets and Therapy?

The journal welcomes submitted papers covering original research, basic science, clinical & epidemiological studies, reviews & evaluations, guidelines, expert opinion and commentary, case reports, and extended reports.

How much does it cost to publish in Blood and Lymphatic Cancer: Targets and Therapy?

Blood and Lymphatic Cancer: Targets and Therapy charges an article processing charge (APC) of about $3,300 for open-access publication.

You May Also Like

See all →
Blood and Lymphatic Cancer: Targets and Therapy
Dove Medical Press
OA
Acta Haematologica
S. Karger AG
SJR Q3SCIE
Blood Neoplasia
Elsevier
SJR Q1OA
Blood Research
Springer
SJR Q2OA
Compare This JournalFind Similar← Back to Search
Understand these signals
How to tell if a journal is predatoryWhat Q1–Q4 quartiles meanWeb of Science vs Scopus vs DOAJWhat is an APC?

Data updated: 2026-05-26 · Sources: SJR, DOAJ, OpenAlex, WoS, Crossref